Home » Topics » Disease categories and therapies » Urology

Urology
RSS

Taisho Pharmaceutical's TP-0463518 in clinical development for renal anemia

Nov. 23, 2016

Regulus chemically modified oligonucleotide for Alport syndrome

Nov. 22, 2016

Sandoz's epoetin alfa biosimilar for renal anemia

Nov. 22, 2016

Pan-Nox inhibitor for diabetic nephropathy

Nov. 22, 2016

Laboratoris Sanifit reports clinical data on SNF-472

Nov. 21, 2016

Apricus plans for Vitaros NDA resubmission next year

Nov. 21, 2016

Resverlogix's apabetalone shows favorable PK profile in severe renal impairment

Nov. 18, 2016

Sanford-Burnham Medical Research Institute patents APJ agonists

Nov. 18, 2016

Reata Pharmaceuticals announces plans to study bardoxolone methyl in new indication

Nov. 15, 2016

ChemoCentryx's CCX-168 leads to improvements in patient with C3 glomerulopathy

Oct. 28, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 22, 2026.
Sangamo presents primate data for prion suppressor ST-506
BioWorld Science
Sangamo Therapeutics Inc. discussed gene regulation approaches for neurodegenerative diseases when presenting findings on their clinical candidate ST-506 for the...
TREM2 agonists detailed in Pfizer patent
BioWorld Science
Pfizer Inc. has reported new triggering receptor expressed on myeloid cells 2 (TREM2) agonists potentially useful for the treatment of neurodegeneration.
Unmasking the X: EPAC2 shifts the fragile X landscape
BioWorld
Researchers at UCLA have shown that divergent neuronal signaling in fragile X mice converges on EPAC2, a druggable target whose inhibition restores circuit...
Recludix presents STAT1/3 inhibitors for dermatological diseases
BioWorld Science
Recludix Pharma Inc. recently presented data on their new STAT1/3 inhibitors REX-6553 and REX-6547 for treating dermatological inflammatory skin diseases.